{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:55:42Z","timestamp":1781373342824,"version":"3.54.1"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.prp.2023.154689","type":"journal-article","created":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:48:09Z","timestamp":1689385689000},"page":"154689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Multiple myeloma and its rare paraneoplastic manifestations simmering under the surface"],"prefix":"10.1016","volume":"248","author":[{"given":"Sehrish Sarwar","family":"Baloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saqib Raza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Wasio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha Arshad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehwish","family":"Shahzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munira","family":"Moosajee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaheena","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsheen","family":"Raza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1886-6710","authenticated-orcid":false,"given":"Shahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154689_bib1","unstructured":"B. Thapa, N. Mahendraker, K. Ramphul, Paraneoplastic Syndromes, in StatPearls. 2023, StatPearls Publishing. Copyright \u00a9 2023, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"17","key":"10.1016\/j.prp.2023.154689_bib2","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1182\/blood-2011-06-358812","article-title":"Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)","volume":"118","author":"Palumbo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.prp.2023.154689_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2007-07-097667","article-title":"Progression risk for MGUS and SMM","volume":"110","author":"Greipp","year":"2007","journal-title":"blood"},{"issue":"12","key":"10.1016\/j.prp.2023.154689_bib4","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23159","article-title":"Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study","volume":"87","author":"Golombick","year":"2012","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.prp.2023.154689_bib7","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long-term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.prp.2023.154689_bib8","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","article-title":"International uniform response criteria for multiple myeloma","volume":"20","author":"Durie","year":"2006","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1600-0609.2005.00531.x","article-title":"Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma","volume":"75","author":"Terpos","year":"2005","journal-title":"Eur. J. Haematol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0889-8588(05)70125-8","article-title":"Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia","volume":"13","author":"Blad\u00e9","year":"1999","journal-title":"Hematol. Oncol. Clin. N. Am."},{"issue":"8","key":"10.1016\/j.prp.2023.154689_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.14740\/jocmr2210w","article-title":"Immunoglobulin D multiple myeloma with rapidly progressing renal failure","volume":"7","author":"Modi","year":"2015","journal-title":"J. Clin. Med. Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1600-0609.1991.tb01569.x","article-title":"A new risk grouping for IgD myeloma based on analysis of 165 Japanese patients","volume":"47","author":"Shimamoto","year":"1991","journal-title":"Eur. J. Haematol."},{"issue":"7","key":"10.1016\/j.prp.2023.154689_bib13","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.21740","article-title":"The outcome of IgD myeloma after autologous hematopoietic stem cell transplantation is similar to other Ig subtypes","volume":"85","author":"Sharma","year":"2010","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib14","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3816\/CLML.2010.n.078","article-title":"Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study","volume":"10","author":"Reece","year":"2010","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib15","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1182\/blood-2002-08-2436","article-title":"Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants","volume":"101","author":"Avet-Loiseau","year":"2003","journal-title":"Blood"},{"issue":"5\u20136","key":"10.1016\/j.prp.2023.154689_bib16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/10428199909058419","article-title":"IgE multiple myeloma","volume":"32","author":"Macro","year":"1999","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.prp.2023.154689_bib17","first-page":"841","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973-2003","volume":"19","author":"Han","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1365-2141.2010.08157.x","article-title":"Plasma cell leukaemia and other aggressive plasma cell malignancies","volume":"150","author":"Sher","year":"2010","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib20","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/leu.2008.4","article-title":"Genetic aberrations and survival in plasma cell leukemia","volume":"22","author":"Tiedemann","year":"2008","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/10428190290006143","article-title":"Thalidomide in low doses is effective for the treatment of resistant or relapsed multiple myeloma and for plasma cell leukaemia","volume":"43","author":"Johnston","year":"2002","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3324\/haematol.2009.013334","article-title":"Primary plasma cell leukemia and autologous stem cell transplantation","volume":"95","author":"Drake","year":"2010","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib23","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood-2007-03-082354","article-title":"Lenalidomide therapy in a patient with POEMS syndrome","volume":"110","author":"Dispenzieri","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.prp.2023.154689_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2169\/internalmedicine.33.583","article-title":"Elevated serum interleukin-6 in POEMS syndrome reflects the activity of the disease","volume":"33","author":"Hitoshi","year":"1994","journal-title":"Intern Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2013-03-487025","article-title":"Outcomes of patients with POEMS syndrome treated initially with radiation","volume":"122","author":"Humeniuk","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood-2012-04-423178","article-title":"Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience","volume":"120","author":"D'Souza","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1182\/blood-2005-03-0910","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"106","author":"Badros","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.prp.2023.154689_bib29","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/art.1780390824","article-title":"All-trans-retinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines","volume":"39","author":"Authier","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/bjh.14497","article-title":"Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen","volume":"181","author":"He","year":"2018","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2141.1993.tb08668.x","article-title":"Sweet's syndrome associated with G-CSF","volume":"85","author":"Payda\u015f","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib32","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.0303-6987.2002.029.x","article-title":"Sweet syndrome in multiple myeloma: a series of six cases","volume":"30","author":"Bayer-Garner","year":"2003","journal-title":"J. Cutan. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib33","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1002\/phar.1383","article-title":"Bortezomib-induced Sweet's syndrome confirmed by rechallenge","volume":"34","author":"Zobniw","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/1658-5127.137158","article-title":"Sweet's syndrome with multiple myeloma","volume":"5","author":"Alsaleh","year":"2014","journal-title":"J. Appl. Hematol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1468-3083.2004.01069.x","article-title":"Paraneoplastic vasculitis associated with multiple myeloma","volume":"18","author":"S\u00e1nchez","year":"2004","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2230.2003.01324.x","article-title":"Leukocytoclastic (small vessel) vasculitis in multiple myeloma","volume":"28","author":"Bayer-Garner","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4103\/0378-6323.29340","article-title":"Cutaneous vasculitis as a presenting feature of multiple myeloma: a report of 2 cases","volume":"72","author":"Kembre","year":"2006","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib38","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1684\/ejd.2010.1223","article-title":"Angiomatoid lesions (leukocytoclastic vasculitis) as paraneoplastic manifestations of multiple myeloma IgA \u03bb","volume":"21","author":"Carlesimo","year":"2011","journal-title":"Eur. J. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1991.01680010079012","article-title":"Cutaneous manifestations of multiple myeloma","volume":"127","author":"Kois","year":"1991","journal-title":"Arch. Dermatol."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.clml.2011.03.034","article-title":"Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing multiple myeloma: a case report","volume":"11","author":"Peterlin","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"9923","key":"10.1016\/j.prp.2023.154689_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.prp.2023.154689_bib42","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2169\/internalmedicine.56.8331","article-title":"Paraneoplastic sarcoidosis in multiple myeloma","volume":"56","author":"Kusaba","year":"2017","journal-title":"Intern. Med."},{"issue":"11","key":"10.1016\/j.prp.2023.154689_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/qjmed\/hcv039","article-title":"Sarcoidosis and lymphoma: a comparative study","volume":"108","author":"Chalayer","year":"2015","journal-title":"QJM"},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.5858\/2002-126-0365-MMIAWS","article-title":"Multiple myeloma in association with sarcoidosis","volume":"126","author":"Sen","year":"2002","journal-title":"Arch. Pathol. Lab Med"},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jbo.2014.02.002","article-title":"Double pathology, sarcoidosis associated with multiple myeloma: a case report","volume":"3","author":"Dachs","year":"2014","journal-title":"J. Bone Oncol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib46","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/0970-2113.173068","article-title":"Sarcoidosis and multiple myeloma: Concurrent presentation of an unusual association","volume":"33","author":"Nair","year":"2016","journal-title":"Lung India"},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib47","first-page":"324","article-title":"Plasmapheresis in a patient with sarcoidosis who developed multiple myeloma and massive free kappa light chains nephropathy","volume":"20","author":"Markel","year":"2018","journal-title":"Isr. Med. Assoc. J."},{"issue":"8","key":"10.1016\/j.prp.2023.154689_bib48","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib49","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00296-014-3170-4","article-title":"Osseous sarcoidosis: a case series","volume":"35","author":"Kuzyshyn","year":"2015","journal-title":"Rheumatol. Int."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.2830440311","article-title":"Coincidental polycythemia vera and multiple myeloma: case report and review","volume":"44","author":"Fink","year":"1993","journal-title":"Am. J. Hematol."},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00000441-194908000-00005","article-title":"Multiple myeloma associated with polycythemia; report of four cases","volume":"218","author":"LAWRENCE","year":"1949","journal-title":"Am. J. Med. Sci."},{"issue":"9","key":"10.1016\/j.prp.2023.154689_bib52","first-page":"1047","article-title":"Multiple myeloma superimposed on chronic myelocytic leukemia","volume":"110","author":"Derghazarian","year":"1974","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.prp.2023.154689_bib53","first-page":"2016","article-title":"Polycythaemia: an unusual presentation of multiple myeloma","author":"Hutchison","year":"2016","journal-title":"BMJ Case Rep."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib54","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1699-0463.1956.tb04663.x","article-title":"Polycythaemia vera with multiple myeloma; report of a case","volume":"38","author":"GIERTSEN","year":"1956","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.prp.2023.154689_bib55","first-page":"1005","article-title":"Polycythemia and quadriplegia in multiple myeloma. a case report","volume":"59","author":"HILL","year":"1963","journal-title":"Ohio State Med. J."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib56","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/ajcp\/82.4.501","article-title":"Polycythemia associated with myeloma","volume":"82","author":"Maeda","year":"1984","journal-title":"Am. J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clml.2013.09.015","article-title":"Coexistence of myeloproliferative neoplasm and plasma-cell dyscrasia","volume":"14","author":"Malhotra","year":"2014","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2169\/internalmedicine1962.28.396","article-title":"Secondary polycythemia associated with multiple myeloma","volume":"28","author":"Inase","year":"1989","journal-title":"Jpn. J. Med"},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib59","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1179\/acb.2009.071","article-title":"Concurrence of multiple myeloma and idiopathic erythrocytosis","volume":"64","author":"Chang","year":"2009","journal-title":"Acta Clin. Belg."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib60","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000328996","article-title":"JAK2 mutation-negative secondary erythrocytosis in smoldering plasma cell myeloma: a case study and review of the literature","volume":"126","author":"Lee","year":"2011","journal-title":"Acta Haematol."},{"issue":"12","key":"10.1016\/j.prp.2023.154689_bib61","first-page":"EL01","article-title":"The JAK2 V617F mutation in plasma cell neoplasms with co-existing erythrocytosis","volume":"9","author":"Langabeer","year":"2015","journal-title":"J. Clin. Diagn. Res."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib62","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJMc1106670","article-title":"The TEMPI syndrome--a novel multisystem disease","volume":"365","author":"Sykes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib63","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/ckj\/sfs139","article-title":"A new case of TEMPI syndrome","volume":"5","author":"Mohammadi","year":"2012","journal-title":"Clin. Kidney J."},{"issue":"19","key":"10.1016\/j.prp.2023.154689_bib64","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMc1202649","article-title":"Bortezomib to treat the TEMPI syndrome","volume":"366","author":"Kwok","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib65","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1182\/blood-2007-11-120576","article-title":"Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1","volume":"111","author":"Shin","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.prp.2023.154689_bib66","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2015.298","article-title":"Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation","volume":"29","author":"Kenderian","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.prp.2023.154689_bib67","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0301-472X(99)00043-0","article-title":"Defective expression of the SHP-1 phosphatase in polycythemia vera","volume":"27","author":"Wickrema","year":"1999","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib68","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/10428190290006350","article-title":"Acute disseminated encephalomyelitis after para-influenza infection post bone marrow transplantation","volume":"43","author":"Au","year":"2002","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.prp.2023.154689_bib69","doi-asserted-by":"crossref","unstructured":"C. Karam, M.L. Mauermann, Neurologic Complications of Myeloma, 2014.","DOI":"10.1007\/978-1-4614-8520-9_20"},{"key":"10.1016\/j.prp.2023.154689_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.msard.2017.01.013","article-title":"Paraneoplastic acute disseminated encephalomyelitis associated with multiple myeloma","volume":"13","author":"Law","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"9","key":"10.1016\/j.prp.2023.154689_bib71","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1080\/10428190410001663581","article-title":"Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma","volume":"45","author":"Urba\u0144ska-Ry\u015b","year":"2004","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib72","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0003-4975(00)01478-8","article-title":"Extramedullary plasmacytoma presenting with myasthenia gravis and mediastinal mass","volume":"70","author":"Ahmed","year":"2000","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib73","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0002-9343(69)90078-3","article-title":"Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality","volume":"46","author":"Rowland","year":"1969","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib74","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12883-020-01813-1","article-title":"Myasthenia gravis with anti-muscle-specific tyrosine kinase antibodies during therapy for multiple myeloma: a case report","volume":"20","author":"Sakano","year":"2020","journal-title":"BMC Neurol."},{"issue":"2","key":"10.1016\/j.prp.2023.154689_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2230.1985.tb00546.x","article-title":"Epidermolysis bullosa acquisita associated with chronic lymphatic leukaemia","volume":"10","author":"Shaw","year":"1985","journal-title":"Clin. Exp. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib76","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clml.2011.06.014","article-title":"Multiple myeloma associated IgA pemphigus: treatment with bortezomib- and lenalidomide-based regimen","volume":"11","author":"Szturz","year":"2011","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"7","key":"10.1016\/j.prp.2023.154689_bib77","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archderm.1993.01680280071014","article-title":"Paraneoplastic pemphigus is a distinct neoplasia-induced autoimmune disease","volume":"129","author":"Camisa","year":"1993","journal-title":"Arch. Dermatol."},{"issue":"2 Pt 1","key":"10.1016\/j.prp.2023.154689_bib78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(08)80621-4","article-title":"Pityriasis rotunda associated with multiple myeloma","volume":"24","author":"Etoh","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib79","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/ced.12396","article-title":"Pityriasis rotunda as an incidental paraneoplastic finding in two patients with multiple myeloma","volume":"39","author":"van Heerden","year":"2014","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib80","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000518420","article-title":"Paraneoplastic filiform hyperkeratosis and immunoglobulin-associated vasculitis in myeloma progression: a case report","volume":"13","author":"Oymanns","year":"2021","journal-title":"Case Rep. Dermatol."},{"issue":"11","key":"10.1016\/j.prp.2023.154689_bib81","first-page":"709","article-title":"Multiple myeloma unveiled by multiple hyperkeratotic spicules","volume":"12","author":"Dalal","year":"2010","journal-title":"Isr. Med Assoc. J."},{"issue":"7","key":"10.1016\/j.prp.2023.154689_bib82","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/ced.12620","article-title":"Necrobiotic xanthogranuloma with multiple myeloma","volume":"40","author":"Bhari","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib83","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jbspin.2005.03.008","article-title":"Necrobiotic xanthogranuloma with multiple myeloma. Case report and pathogenic hypotheses","volume":"73","author":"Langlois","year":"2006","journal-title":"Jt. Bone Spine"},{"issue":"12","key":"10.1016\/j.prp.2023.154689_bib84","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5070\/D30RR0B85W","article-title":"Necrobiotic xanthogranuloma","volume":"18","author":"Rose","year":"2012","journal-title":"Dermatol. Online J."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib85","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1684\/ejd.2018.3256","article-title":"Necrobiotic xanthogranuloma: a paraneoplastic skin lesion of haematological malignancies?","volume":"28","author":"Omarjee","year":"2018","journal-title":"Eur. J. Dermatol."},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib86","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000452826","article-title":"Necrobiotic xanthogranuloma in a patient with multiple myeloma","volume":"8","author":"Wruhs","year":"2016","journal-title":"Case Rep. Dermatol."},{"issue":"5","key":"10.1016\/j.prp.2023.154689_bib87","first-page":"598","article-title":"Solitary necrobiotic xanthogranuloma of an upper extremity in association with multiple myeloma","volume":"13","author":"Bain","year":"2014","journal-title":"J. Drugs Dermatol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib88","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jmv.2016.07.001","article-title":"Paraneoplastic systemic sclerosis: About 3 cases and review of literature","volume":"41","author":"Monfort","year":"2016","journal-title":"J. Mal. Vasc."},{"key":"10.1016\/j.prp.2023.154689_bib89","article-title":"Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature","volume":"2017","author":"Colaci","year":"2017","journal-title":"Case Rep. Rheumatol."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib90","first-page":"85","article-title":"Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma","volume":"20","author":"Bachleitner-Hofmann","year":"2002","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.prp.2023.154689_bib91","first-page":"2013","article-title":"Coexistence of scleroderma with multiple myeloma: a rare association","author":"Gajendra","year":"2013","journal-title":"BMJ Case Rep."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib92","first-page":"316","article-title":"Systemic sclerosis and myositis as a paraneoplastic syndrome secondary to multiple myeloma","volume":"43","author":"Santos-Faria","year":"2018","journal-title":"Acta Reumatol. Port."},{"key":"10.1016\/j.prp.2023.154689_bib93","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1750-1172-2-34","article-title":"Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis","volume":"2","author":"Cohen","year":"2007","journal-title":"Orphanet J. Rare Dis."},{"issue":"10","key":"10.1016\/j.prp.2023.154689_bib94","first-page":"1175","article-title":"Acquired amylase production induced by radiotherapy in a myeloma patient","volume":"36","author":"Yamakawa","year":"1995","journal-title":"Rinsho Ketsueki"},{"issue":"Pt 6","key":"10.1016\/j.prp.2023.154689_bib95","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/000456320203900615","article-title":"Hyperamylasaemia and multiple myeloma","volume":"39","author":"Ross","year":"2002","journal-title":"Ann. Clin. Biochem."},{"issue":"876","key":"10.1016\/j.prp.2023.154689_bib96","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1136\/pgmj.74.876.621","article-title":"Metastatic multiple myeloma with hyperamylasaemia and hyperlipasaemia","volume":"74","author":"Nair","year":"1998","journal-title":"Post. Med. J."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib97","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0300-2977(95)00110-7","article-title":"Hyperamylasaemia in multiple myeloma","volume":"49","author":"Bloemendal","year":"1996","journal-title":"Neth. J. Med."},{"issue":"1","key":"10.1016\/j.prp.2023.154689_bib98","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10428190500262144","article-title":"Amylase: a disease activity index in multiple myeloma?","volume":"47","author":"Pinelli","year":"2006","journal-title":"Leuk. Lymphoma"},{"issue":"8","key":"10.1016\/j.prp.2023.154689_bib99","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/1097-0142(19881015)62:8<1511::AID-CNCR2820620811>3.0.CO;2-L","article-title":"Ectopic production of salivary-type amylase by a IgA-lambda-type multiple myeloma","volume":"62","author":"Hata","year":"1988","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib100","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000100931","article-title":"Paraneoplastic hyperamylasaemia in association with multiple myeloma","volume":"117","author":"Calvo-Villas","year":"2007","journal-title":"Acta Haematol."},{"issue":"6","key":"10.1016\/j.prp.2023.154689_bib101","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1515\/tjb-2016-0152","article-title":"A rare cause of hyperamylasemia: multiple myeloma","volume":"41","author":"Sincan","year":"2016","journal-title":"Turk. J. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib102","first-page":"267","article-title":"Cutis laxa acquisita associated with multiple myeloma: a case report and review of the literature","volume":"57","author":"McCarty","year":"1996","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.prp.2023.154689_bib103","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/01676830.2011.648808","article-title":"Marked bilateral lower eyelid ectropion in cutis laxa: a paraneoplastic process in multiple myeloma","volume":"31","author":"Slingerland","year":"2012","journal-title":"Orbit"},{"issue":"4","key":"10.1016\/j.prp.2023.154689_bib104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archinte.1966.00290160051010","article-title":"Polycythemia vera associated with lymphomatous diseases and myeloma","volume":"118","author":"Heinle","year":"1966","journal-title":"Arch. Intern. Med."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823003898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:33:56Z","timestamp":1774409636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823003898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":104,"alternative-id":["S0344033823003898"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154689","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple myeloma and its rare paraneoplastic manifestations simmering under the surface","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154689"}}